NM_000532.5:c.49C>A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2

The NM_000532.5(PCCB):​c.49C>A​(p.Leu17Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00242 in 1,589,370 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L17L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0016 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0025 ( 3 hom. )

Consequence

PCCB
NM_000532.5 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:9

Conservation

PhyloP100: 0.372

Publications

9 publications found
Variant links:
Genes affected
PCCB (HGNC:8654): (propionyl-CoA carboxylase subunit beta) The protein encoded by this gene is a subunit of the propionyl-CoA carboxylase (PCC) enzyme, which is involved in the catabolism of propionyl-CoA. PCC is a mitochondrial enzyme that probably acts as a dodecamer of six alpha subunits and six beta subunits. This gene encodes the beta subunit of PCC. Defects in this gene are a cause of propionic acidemia type II (PA-2). Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
PCCB Gene-Disease associations (from GenCC):
  • propionic acidemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Myriad Women’s Health, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 61 curated pathogenic missense variants (we use a threshold of 10). The gene has 6 curated benign missense variants. Gene score misZ: -0.86701 (below the threshold of 3.09). Trascript score misZ: -0.97134 (below the threshold of 3.09). GenCC associations: The gene is linked to propionic acidemia.
BP4
Computational evidence support a benign effect (MetaRNN=0.0063657463).
BP6
Variant 3-136250424-C-A is Benign according to our data. Variant chr3-136250424-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 203883.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCCBNM_000532.5 linkc.49C>A p.Leu17Met missense_variant Exon 1 of 15 ENST00000251654.9 NP_000523.2 P05166-1
PCCBNM_001178014.2 linkc.49C>A p.Leu17Met missense_variant Exon 1 of 16 NP_001171485.1 P05166-2
PCCBXM_011512873.2 linkc.49C>A p.Leu17Met missense_variant Exon 1 of 11 XP_011511175.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCCBENST00000251654.9 linkc.49C>A p.Leu17Met missense_variant Exon 1 of 15 1 NM_000532.5 ENSP00000251654.4 P05166-1

Frequencies

GnomAD3 genomes
AF:
0.00159
AC:
242
AN:
152270
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00295
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00153
AC:
313
AN:
204210
AF XY:
0.00151
show subpopulations
Gnomad AFR exome
AF:
0.000511
Gnomad AMR exome
AF:
0.000496
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000842
Gnomad NFE exome
AF:
0.00310
Gnomad OTH exome
AF:
0.000983
GnomAD4 exome
AF:
0.00250
AC:
3598
AN:
1436982
Hom.:
3
Cov.:
31
AF XY:
0.00236
AC XY:
1684
AN XY:
712736
show subpopulations
African (AFR)
AF:
0.000393
AC:
13
AN:
33052
American (AMR)
AF:
0.000510
AC:
21
AN:
41204
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25308
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38550
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83246
European-Finnish (FIN)
AF:
0.000966
AC:
49
AN:
50738
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5690
European-Non Finnish (NFE)
AF:
0.00312
AC:
3435
AN:
1099870
Other (OTH)
AF:
0.00133
AC:
79
AN:
59324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
206
412
619
825
1031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00159
AC:
242
AN:
152388
Hom.:
2
Cov.:
33
AF XY:
0.00138
AC XY:
103
AN XY:
74520
show subpopulations
African (AFR)
AF:
0.000553
AC:
23
AN:
41600
American (AMR)
AF:
0.000588
AC:
9
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00295
AC:
201
AN:
68042
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
13
26
40
53
66
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00150
Hom.:
0
Bravo
AF:
0.00144
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000686
AC:
3
ESP6500EA
AF:
0.00317
AC:
27
ExAC
AF:
0.00144
AC:
173
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:9
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Dec 02, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 26, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 12757933, 10447268, 27896094) -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Propionic acidemia Uncertain:1Benign:2
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Jun 16, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:2
Feb 24, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: PCCB c.49C>A (p.Leu17Met) results in a conservative amino acid change located in the mitochondrial leader sequence (Chloupkova_2002) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0015 in 204310 control chromosomes, predominantly at a frequency of 0.0031 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 1.3 fold of the estimated maximal expected allele frequency for a pathogenic variant in PCCB causing Propionic Acidemia phenotype (0.0025), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.49C>A has been reported in the literature in individuals affected with Propionic Acidemia (Muro_1999, Kruszka_2014). These reports do not provide unequivocal conclusions about association of the variant with Propionic Acidemia. At least one co-occurrence with another pathogenic variant has been reported (PCCB c.790dupG, p.Asp264Glyfs*3, Muro_1999), providing supporting evidence for a benign role. At least one publication reports experimental evidence evaluating an impact on protein function. These results showed no damaging effect of this variant. Six ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance (n=1), likely benign (n=4) and benign (n=1). Based on the evidence outlined above, the variant was classified as likely benign. -

Jul 25, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PCCB-related disorder Benign:1
Oct 18, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.092
T
BayesDel_noAF
Uncertain
0.090
CADD
Benign
14
DANN
Benign
0.92
DEOGEN2
Benign
0.33
T;.;.;T;T;T;.;.;.;.;T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.33
N
LIST_S2
Benign
0.76
T;T;T;T;T;T;T;T;T;T;T
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.0064
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.40
D
MutationAssessor
Benign
0.0
N;.;.;.;.;.;.;.;N;.;.
PhyloP100
0.37
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.39
N;N;N;N;N;N;N;N;N;N;N
REVEL
Uncertain
0.59
Sift
Benign
0.062
T;T;T;D;T;T;T;D;D;D;D
Sift4G
Benign
0.24
T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.036
B;.;.;.;.;.;.;B;.;.;.
Vest4
0.27
MVP
0.67
MPC
0.097
ClinPred
0.019
T
GERP RS
0.74
PromoterAI
0.11
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.077
gMVP
0.44
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200185747; hg19: chr3-135969266; COSMIC: COSV52443558; COSMIC: COSV52443558; API